These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 2538263)
41. [Usefulness of transcatheter arterial embolization (TAE) for large hepatocellular carcinoma using a lecithin-added Lipiodol emulsion]. Kobayashi S; Otsubo T; Koizumi S; Yoshitoshi K; Katagiri S; Furukawa T; Yamamoto M; Takasaki K Nihon Shokakibyo Gakkai Zasshi; 2007 Nov; 104(11):1601-6. PubMed ID: 17984608 [TBL] [Abstract][Full Text] [Related]
42. Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter). Nakamura H; Hashimoto T; Inoue Y; Inoue K; Akaji H; Sawada S Radiat Med; 1990; 8(5):188-90. PubMed ID: 1963695 [TBL] [Abstract][Full Text] [Related]
43. [One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma]. Tanikawa K; Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Abe M Gan To Kagaku Ryoho; 1985 Oct; 12(10):1930-7. PubMed ID: 2996439 [TBL] [Abstract][Full Text] [Related]
44. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075 [TBL] [Abstract][Full Text] [Related]
45. [Pharmacological and clinical studies on lipiodol emulsion for hepatocellular carcinoma]. Kodama T; Arima K; Sakamoto H; Suga M; Yachi A Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2544-8. PubMed ID: 2843121 [TBL] [Abstract][Full Text] [Related]
46. Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe. Terayama N; Miyayama S; Tatsu H; Yamamoto T; Toya D; Tanaka N; Mitsui T; Miura S; Fujisawa M; Kifune K; Matsui O; Takashima T J Vasc Interv Radiol; 1998; 9(3):501-8. PubMed ID: 9618113 [TBL] [Abstract][Full Text] [Related]
47. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Ono Y; Yoshimasu T; Ashikaga R; Inoue M; Shindou H; Fuji K; Araki Y; Nishimura Y Am J Clin Oncol; 2000 Dec; 23(6):564-8. PubMed ID: 11202797 [TBL] [Abstract][Full Text] [Related]
48. [Prognosis of intra-arterial chemo-embolization in metastatic liver cancer]. Ito K; Hattori F; Takagi A; Kida M; Tanaka K; Matsumoto H; Kojima K; Iseki J; Toyama K; Nakajima N Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3041-4. PubMed ID: 2551244 [TBL] [Abstract][Full Text] [Related]
49. [Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report]. Sawada Y; Iwamoto S; Yurino N; Fujii S; Murai N; Okuno F; Kotake H; Mashiba H Gan To Kagaku Ryoho; 1991 Nov; 18(14):2471-5. PubMed ID: 1659329 [TBL] [Abstract][Full Text] [Related]
50. [Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study]. Kawai S; Tani M; Mikuriya S; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Jinno K; Makino M; Oda T Gan To Kagaku Ryoho; 1990 Feb; 17(2):227-32. PubMed ID: 2154160 [TBL] [Abstract][Full Text] [Related]
51. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919 [TBL] [Abstract][Full Text] [Related]
52. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma]. Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119 [TBL] [Abstract][Full Text] [Related]
53. [Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis]. Takagi H; Abe T; Uehara M; Saitoh S; Takayama H; Ojima T; Iizuka H; Katakai S; Takezawa J; Nagamine T Gan No Rinsho; 1988 Mar; 34(3):347-55. PubMed ID: 2833637 [TBL] [Abstract][Full Text] [Related]
54. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma]. Jin-no K Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695 [TBL] [Abstract][Full Text] [Related]
55. [Transcatheter arterial embolization of hepatocellular carcinoma using CO2-US]. Miyajima Y; Sakaguchi S; Tohara K Nihon Rinsho; 1998 Apr; 56(4):990-3. PubMed ID: 9577622 [TBL] [Abstract][Full Text] [Related]
56. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence. Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681 [TBL] [Abstract][Full Text] [Related]
57. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma]. Ihaya T; Ametani M; Matsusue E Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698 [TBL] [Abstract][Full Text] [Related]
58. Prevention of gastric complications in hepatic arterial chemoembolization. Balloon catheter occlusion technique. Nakamura H; Hashimoto T; Oi H; Sawada S; Furui S Acta Radiol; 1991 Jan; 32(1):81-2. PubMed ID: 1849417 [TBL] [Abstract][Full Text] [Related]
59. Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma. Kim JH; Chung JW; Han JK; Park JH; Choi BI; Han MC J Vasc Interv Radiol; 1995; 6(1):71-4; discussion 75-7. PubMed ID: 7703585 [No Abstract] [Full Text] [Related]
60. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Kawai S; Okamura J; Ogawa M; Ohashi Y; Tani M; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C Cancer Chemother Pharmacol; 1992; 31 Suppl():S1-6. PubMed ID: 1281041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]